MODERNA (MRNA)

$28.35 0.00 (0.00%)

20:00 EDT MRNA Stock Quote Delayed 30 Minutes

7 Blue-Chip Stocks That Have Serious Potential for the Long Haul

By Josh Enomoto, InvestorPlace Contributor May 4, 2023

While the top enterprises command significant attention, these hidden gem blue-chip stocks to buy now offer serious potential.

The 3 Most Talked-About Stocks and Cryptos Right Now

7 Healthcare Stocks With Huge Return Potential for Long-Term Investors

3 Cash-Rich Biotech Stocks to Bet on for the Long Haul

Volume:

Previous Close $31.12

Market Cap 12.01B

PE Ratio -3.06

EPS -9.2737

Volume (Avg. Vol.) 20.43M

Day's Range $26.80 - $28.95

52-Week Range $26.80 - $170.47

Dividend & Yield N/A (N/A)

MRNA Stock Predictions, Articles, and MODERNA News

Moderna (MRNA) Stock Sinks Despite Positive Cancer Vaccine Update

By Larry Ramer, InvestorPlace Contributor Apr 17, 2023

MRNA stock is sinking this morning despite Moderna releasing positive Phase 2b data on its mRNA cancer vaccine yesterday.

3 Overvalued Blue-Chip Stocks Not Worth Your Green

By Faizan Farooque, InvestorPlace Contributor Apr 11, 2023

Overvalued blue-chip stocks are the ones to avoid right now, as the markets continue to figure out where the economy is headed next.

7 Sorry Blue-Chip Stocks to Sell in April Before It’s Too Late

By Joel Baglole, InvestorPlace Contributor Apr 4, 2023

These once dominant blue-chip names have fallen out of favor with investors and should be sold before more damage is done.

7 Blue-Chip Stocks Sitting in the Sweet Spot

By Josh Enomoto, InvestorPlace Contributor Mar 23, 2023

Although blue-chip stocks carry a reputation for being bulky and not exciting, these large enterprises can really move.

ChatGPT Says These 7 Stocks Could Be the Next Trillion-Dollar Companies

By Samuel O'Brient, InvestorPlace Reporter Mar 15, 2023

Are you looking for the next trillion-dollar companies? Here are the stocks that ChatGPT thinks will help make you rich in the coming years.

3 Vaccine Stocks to Watch for Their Post-Pandemic Moves

By John Blankenhorn, InvestorPlace Contributor Mar 14, 2023

The vaccine stocks Pfizer, Moderna, and Novavax all have approved Covid-19 vaccines. They'll soon need new sources of revenue.

February’s 7 Worst-Performing S&P 500 Stocks to Buy on the Cheap

By Will Ashworth, InvestorPlace Contributor Mar 9, 2023

If you’re a contrarian investor, the best S&P 500 stocks to buy could be companies underperforming in recent times. Here are seven examples.

7 Over-$100 Stocks That Are Worth Every Penny

By Louis Navellier and the InvestorPlace Research Staff Mar 3, 2023

To get most of the best-known stocks, you have to be prepared to pay at least $100 per share. Here are seven stocks to buy.

I Asked ChatGPT for 10 Meme Stocks to Buy. Here’s What It Recommended.

By Brenden Rearick, InvestorPlace Financial News Writer Mar 2, 2023

I asked ChatGPT to define what makes a meme stock a meme stock. I also tasked it with picking out some of its favorites.

NVAX Stock Alert: Is Novavax Going Bankrupt?

By Joel Baglole, InvestorPlace Contributor Mar 1, 2023

NVAX stock is tanking after the pharma company said it might not be able to continue operations as sales of its Covid-19 vaccine are weak.

Why Is Moderna (MRNA) Stock Down 5% Today?

By Dana Blankenhorn, InvestorPlace Contributor Feb 17, 2023

If Moderna's new formulation works the latest failure will be a short-term hiccup. But MRNA stock also faces legal and PR challenges.

7 Hot Healthcare Stocks With the Potential to Outperform

By Joel Baglole, InvestorPlace Contributor Feb 15, 2023

These healthcare stocks to buy now have the potential to outperform the market over the long-term because their businesses are strong.

The 7 Most Undervalued Biotech Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 2, 2023

Get your hands on the latest medical innovations at a compelling discount with the most undervalued biotech stocks to buy.

The 7 Most Undervalued Nasdaq Stocks to Buy in February 2023

By Josh Enomoto, InvestorPlace Contributor Feb 1, 2023

For those seeking the best discounts in the tech-centered index, these are the most undervalued Nasdaq stocks to buy.

Thursday Predictions: 3 Hot Stocks for Tomorrow

By Bret Kenwell, InvestorPlace Contributor Jan 25, 2023

Airline stocks, credit card stocks, and vaccine stocks are our focus when it comes to the hot stocks for tomorrow. Here's why.

Moderna (MRNA) Stock Pops on RSV Vaccine Trial Results

By William White, InvestorPlace Writer Jan 18, 2023

Moderna (MRNA) stock is on the move Wednesday alongside positive results from its latest Phase 3 mRNA-1345 vaccine trial.

7 Hot Healthcare Stocks to Watch in 2023

By Joel Baglole, InvestorPlace Contributor Jan 11, 2023

Strong earnings and robust dividend payments make healthcare stocks attractive during times of uncertainty and volatility.

CytomX Therapeutics (CTMX) Stock Jumps 50% on Moderna Deal

By Josh Enomoto, InvestorPlace Contributor Jan 6, 2023

CytomX Therapeutics announced a licensing deal with Moderna, which may supercharge the underlying ambitions of CTMX stock.

7 Stocks to Buy on the Dip as the S&P 500 Falters

By Joel Baglole, InvestorPlace Contributor Dec 14, 2022

With the benchmark S&P 500 index continuing to be volatile, the share prices of many great companies are trading sideways or falling further from their highs. While the ongoing market churn can be stressful, it also presents a fantastic opportunity for investors to buy into some great stocks.

Moderna (MRNA) Stock Soars on Cancer Vaccine News

By William White, InvestorPlace Writer Dec 13, 2022

Moderna (MRNA) stock is rising higher on Tuesday following the release of data from a Phase 2B cancer vaccine clinical trial.

MODERNA (MRNA)

7 Blue-Chip Stocks That Have Serious Potential for the Long Haul

The 3 Most Talked-About Stocks and Cryptos Right Now

7 Healthcare Stocks With Huge Return Potential for Long-Term Investors

3 Cash-Rich Biotech Stocks to Bet on for the Long Haul

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MODERNA (MRNA)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRNA Stock Predictions, Articles, and MODERNA News

Subscriber Sign in